Full Press Release Details
NORTH CHICAGO, Ill. , May 21, 2020 /PRNewswire/ -- AbbVie, a research-based global biopharmaceutical company, today announced donations to 26 nonprofit organizations totaling $5 million to support immediate COVID-19 relief efforts. Through support from the newly created AbbVie COVID-19 Community Resilience Fund, these organizations will help front-line healthcare workers and vulnerable populations in hard-hit communities.
"At AbbVie, we believe that we should all do our part to alleviate the burden of this global health crisis," said Laura Schumacher , Vice Chairman External Affairs and Chief Legal Officer, AbbVie. "With this support, our partners – from large, well-known international organizations to local, community-based nonprofits – will be able to bring more relief to front-line healthcare workers and society's most vulnerable populations. We are proud to support our partners as they address difficult challenges in this time of dire need."
As a result of AbbVie's donation, national and global nonprofit organizations will:
"COVID-19 affects us all – our kids, our communities and beyond. But as with any disaster, vulnerable children will suffer most. Since the onset of the pandemic, Save the Children has been working around the clock to meet the urgent needs of kids, including access to food, learning resources and social and emotional support for children living in some of America's most rural communities," said Mark Shriver, Senior Vice President of U.S. Programs and Advocacy at Save the Children. "We are incredibly grateful to AbbVie for supporting these efforts. On behalf of children and their families across America who will benefit from this investment, thank you."
"AbbVie's support will help Sinai Health System provide the kind of care every Chicagoan deserves, especially in our vulnerable communities on Chicago's west and southwest sides," said Karen Teitelbaum , President and CEO of Sinai Health System. "The patients we serve are especially at risk for COVID-19, and these funds will allow Sinai to provide testing, treatment, and rehabilitative care for those in the greatest need."
The COVID-19 Community Resilience Fund is part of AbbVie's broader $35 million philanthropic contribution to COVID-19 relief efforts that also include donations to partners International Medical Corps, Direct Relief and Feeding America. A complete list of COVID-19 Community Resilience Fund donations is below.
AbbVie's Response to COVID-19
During the pandemic, in addition to philanthropic support, AbbVie has been working to ensure that our business continues to operate properly, our employees remain safe and our patients continue to receive their medicines. For additional information about AbbVie's response to COVID-19, please visit AbbVie.com .
AbbVie is a global, research and development-based biopharmaceutical company committed to developing innovative advanced therapies for some of the world's most complex and critical conditions. The company's mission is to use its expertise, dedicated people and unique approach to innovation to markedly improve treatments across four primary therapeutic areas: immunology, oncology, virology and neuroscience. In more than 75 countries, AbbVie employees are working every day to advance health solutions for people around the world. For more information about AbbVie, please visit us at www.abbvie.com . Follow @abbvie on Twitter, Facebook , LinkedIn or Instagram .
Chicagoland Area
Across the U.S.
Specific U.S. Cities